The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis
Open accessAbstract
The molecular basis for isoniazid resistance in Mycobacterium tuberculosis is complex. Putative isoniazid resistance mutations have been identified in katG , ahpC , inhA , kasA , and ndh . However, small sample sizes and related potential biases in sample selection have precluded the development of statistically valid and significant population genetic analyses of clinical isoniazid resistance. We present the first large-scale analysis of 240 alleles previously associated with isoniazid resistance in a diverse set of 608 isoniazid-susceptible and 403 isoniazid-resistant clinical M. tuberculosis isolates. We detected 12 mutant alleles in isoniazid-susceptible isolates, suggesting that these alleles are not involved in isoniazid resistance. However, mutations in katG , ahpC , and inhA were strongly associated with isoniazid resistance, while kasA mutations were associated with isoniazid susceptibility. Remarkably, the distribution of isoniazid resistance-associated mutations was different in isoniazid-monoresistant isolates from that in multidrug-resistant isolates, with significantly fewer isoniazid resistance mutations in the isoniazid-monoresistant group. Mutations in katG 315 were significantly more common in the multidrug-resistant isolates. Conversely, mutations in the inhA promoter were significantly more common in isoniazid-monoresistant isolates. We tested for interactions among mutations and resistance to different drugs. Mutations in katG , ahpC , and inhA were associated with rifampin resistance, but only katG 315 mutations were associated with ethambutol resistance. There was also a significant inverse association between katG 315 mutations and mutations in ahpC or inhA and between mutations in kasA and mutations in ahpC . Our results suggest that isoniazid resistance and the evolution of multidrug-resistant strains are complex dynamic processes that may be influenced by interactions between genes and drug-resistant phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kamerbeek, J., Schouls, L., Kolk, A., van Agterveld, M., van Soolingen, D., Kuijper, S., Bunschoten, A., Molhuizen, H., Shaw, R., Goyal, M., et al. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.4.907-914.1997 · Cited by 2,858
Clinical Microbiology Procedures Handbook
(2016) · ASM Press eBooks · doi:10.1128/9781555818814 · Cited by 2,240
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389 · cited 2×
“Laboratory studies have suggested that expression of the inhA gene may be tightly regulated, as inhA cannot be overexpressed on a multicopy plasmid using its native promoter (5).”
BackgroundThe catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992) · Nature · doi:10.1038/358591a0 · Cited by 1,299
Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
Ramaswamy, S., & Musser, J. M. (1998) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0002 · Cited by 1,089
Sreevatsan, S., Pan, X., Stockbauer, K. E., Connell, N. D., Kreiswirth, B. N., Whittam, T. S., & Musser, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9869 · Cited by 1,024
Alland, D., Kalkut, G. E., Moss, A. R., McAdam, R. A., Hahn, J. A., Bosworth, W., Drucker, E., & Bloom, B. R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406163302403 · Cited by 799
Self-citationModification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis
Rozwarski, D. A., Grant, G. A., Barton, D. H. R., Jacobs, W. R., & Sacchettini, J. C. (1998) · Science · doi:10.1126/science.279.5347.98 · Cited by 682
Global Trends in Resistance to Antituberculosis Drugs
Espinal, M. A., Laszlo, A., Simonsen, L., Boulahbal, F., Kim, S. J., Reniero, A., Hoffner, S., Rieder, H. L., Binkin, N., Dye, C., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441706 · Cited by 671
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
Musser, J. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.496 · Cited by 621
Frothingham, R., & Meeker-O’Connell, W. A. (1998) · Microbiology · doi:10.1099/00221287-144-5-1189 · Cited by 589
Compensatory ahp C Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis
Sherman, D. R., Mdluli, K., Hickey, M. J., Arain, T. M., Morris, S. L., Barry, C. E., & Stover, C. K. (1996) · Science · doi:10.1126/science.272.5268.1641 · Cited by 436
Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP Synthase by Isoniazid
Mdluli, K., Slayden, R. A., Zhu, Y., Ramaswamy, S., Pan, X., Mead, D., Crane, D. D., Musser, J. M., & Barry, C. E. (1998) · Science · doi:10.1126/science.280.5369.1607 · Cited by 398
Ramaswamy, S. V., Reich, R., Dou, S.-J., Jasperse, L., Pan, X., Wanger, A., Quitugua, T., & Graviss, E. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1241-1250.2003 · Cited by 336
Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations
Sreevatsan, S., Stockbauer, K. E., Pan, X., Kreiswirth, B. N., Moghazeh, S. L., Jacobs, W. R., Telenti, A., & Musser, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1677 · Cited by 335
Rawat, R., Whitty, A., & Tonge, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235848100 · Cited by 330
Musser, J. M., Kapur, V., Williams, D. L., Kreiswirth, B. N., van Soolingen, D., & van Embden, J. D. A. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.1.196 · Cited by 313
Altered NADH/NAD + Ratio Mediates Coresistance to Isoniazid and Ethionamide in Mycobacteria
Vilchèze, C., Weisbrod, T. R., Chen, B., Kremer, L., Hazbón, M. H., Wang, F., Alland, D., Sacchettini, J. C., & Jacobs, W. R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.708-720.2005 · Cited by 284
Self-citationPym, A. S., Saint-Joanis, B., & Cole, S. T. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.4955-4960.2002 · Cited by 278
Piatek, A. S., Telenti, A., Murray, M. R., El-Hajj, H., Jacobs, W. R., Kramer, F. R., & Alland, D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.103-110.2000 · Cited by 218
Self-citationLarsen, M. H., Vilchèze, C., Kremer, L., Besra, G. S., Parsons, L., Salfinger, M., Heifets, L., Hazbon, M. H., Alland, D., Sacchettini, J. C., et al. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03162.x · Cited by 202
Self-citationNovel Mutations in ndh in Isoniazid-Resistant Mycobacterium tuberculosis Isolates
Lee, A. S. G., Teo, A. S. M., & Wong, S.-Y. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2157-2159.2001 · Cited by 168
Rouse, D. A., Li, Z., Bai, G. H., & Morris, S. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2472 · Cited by 160
Trends in Drug-Resistant Tuberculosis in the United States, 1993-1996
Moore, M. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550100059039 · Cited by 159
Rouse, D. A., DeVito, J. A., Li, Z., Byer, H., & Morris, S. L. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.00133.x · Cited by 158
Marttila, H., Soini, H., Eerola, E., Vyshnevskaya, E. B., Vyshnevskiy, B. I., Otten, T. F., Vasilyef, A. V., & Viljanen, M. K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2443 · Cited by 158
Miesel, L., Weisbrod, T. R., Marcinkeviciene, J. A., Bittman, R., & Jacobs, W. R. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.9.2459-2467.1998 · Cited by 155
Zhang, M., Yue, J., Yang, Y., Zhang, H., Lei, J.-Q., Jin, R., Zhang, X., & Wang, H. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.11.5477-5482.2005 · Cited by 155
Sreevatsan, S., Pan, X., Zhang, Y., Deretic, V. P., & Musser, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.600 · Cited by 152
Gunter, S. E. (1996) · College English · doi:10.2307/378466 · Cited by 151
Schaeffer, M. L., Agnihotri, G., Volker, C., Kallender, H., Brennan, P. J., & Lonsdale, J. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108903200 · Cited by 148
ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex
Wilson, T. M., & Collins, D. M. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.449980.x · Cited by 148
Will tuberculosis become resistant to all antibiotics?
Dye, C., & Espinal, M. (2001) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2000.1328 · Cited by 148
Transmission of Tuberculosis Among the Urban Homeless
Barnes, P. F. (1996) · JAMA · doi:10.1001/jama.1996.03530280057037 · Cited by 137
Lee, A. S. G., Lim, I. H. K., Tang, L. L. H., Telenti, A., & Wong, S. Y. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.2087 · Cited by 127
Saint‐Joanis, B., Souchon, H., Wilming, M., Johnsson, K., Alzari, P. M., & Cole, S. T. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3380753 · Cited by 126
Hazbón, M. H., Bobadilla-del-Valle, M., Guerrero, M. I., Basil, M. V., Filliol, I., Cavatore, M., Colangeli, R., Safi, H., Billman‐Jacobe, H., Lavender, C. J., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3794-3802.2005 · Cited by 125
Self-citationClinical Consequences and Transmissibility of Drug-Resistant Tuberculosis in Southern Mexico
García-García, M. D. L., Ponce‐de‐León, A., Jiménez-Corona, M. E., Jiménez-Corona, A., Palacios-Martínez, M., Balandrano, S., Ferreyra-Reyes, L. D., Juárez-Sandino, L., Sifuentes‐Osornio, J., Olivera-Díaz, H., et al. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.5.630 · Cited by 125
Self-citationCockerill, F. R., Uhl, J. R., Temesgen, Z., Zhang, Y., Stockman, L., Roberts, G. D., Williams, D. L., & Kline, B. C. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.1.240 · Cited by 114
A Longitudinal Study of Transmission of Tuberculosis in a Large Prison Population
Cháves, F., Dronda, F., Cave, M. D., et al. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.2.9032218 · Cited by 107
Self-citationAlland, D., Whittam, T. S., Murray, M. B., Cave, M. D., Hazbón, M. H., Dix, K., Kokoris, M. S., Duesterhoeft, A., Eisen, J. A., Fraser, C. M., et al. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.11.3392-3399.2003 · Cited by 106
Self-citationGenotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico
Ramaswamy, S. V., Dou, S.-J., Rendón, A., Yang, Z., Cave, M. D., & Graviss, E. A. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05343-0 · Cited by 103
Self-citationLee, C.-N., & Heifets, L. B. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.2.349 · Cited by 91
Wei, C., Lei, B., Musser, J. M., & Tu, S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.670-675.2003 · Cited by 89
Parsons, L. M., Salfinger, M., Clobridge, A., Dormandy, J., Mirabello, L. J., Polletta, V. L., Saniç, A., Sinyavskiy, O., Larsen, S. C., Driscoll, J. R., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2218-2225.2005 · Cited by 81
Baker, L. V., Brown, T., Maxwell, O., Gibson, A. L., Fang, Z., Yates, M. D., & Drobniewski, F. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1455-1464.2005 · Cited by 78
Lavender, C. J., Globan, M., Sievers, A. S., Billman‐Jacobe, H., & Fyfe, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4068-4074.2005 · Cited by 70
Self-citationDrug-resistant tuberculosis in South African gold miners: incidence and associated factors.
Churchyard, G., Corbett, E. L., Kleinschmidt, I., Mulder, D. W., & Cock, K. M. D. (2000) · PubMed · Cited by 69
Bakonytė, D., Baranauskaite, A., Cicenaite, J., Sosnovskaja, A., & Stakėnas, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.2009-2011.2003 · Cited by 69
SCHROEDER, E., Basso, L. A., Santos, D. S., & de Souza, O. N. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.053512 · Cited by 54
Fang, Z., Doig, C., Rayner, A. W., Kenna, D., Watt, B., & Forbes, K. J. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.4.998-1003.1999 · Cited by 45
Cited by
Mycolic Acids: Structures, Biosynthesis, and Beyond
Marrakchi, H., Lanéelle, M.-A., & Daffé, M. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.11.011 · Cited by 623
The Population Dynamics and Control of Tuberculosis
Dye, C., & Williams, B. G. (2010) · Science · doi:10.1126/science.1185449 · Cited by 604
Almeida Da Silva, P. E., & Palomino, J. C. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr173 · Cited by 532
Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives
Gygli, S. M., Borrell, S., Trauner, A., & Gagneux, S. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux011 · Cited by 457
Drug Resistance Mechanisms in Mycobacterium tuberculosis
Palomino, J., & Martin, A. (2014) · Antibiotics · doi:10.3390/antibiotics3030317 · Cited by 442
Metadata
- Authors
- Hazbón, M. H., Brimacombe, M., Bobadilla del Valle, M., Cavatore, M., Guerrero, M. I., Varma-Basil, M., Billman-Jacobe, H., Lavender, C., Fyfe, J., García-García, L., León, C. I., Bose, M., Chaves, F., Murray, M., Eisenach, K. D., Sifuentes-Osornio, J., Cave, M. D., Ponce de León, A., & Alland, D.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2006-08
- Volume
- 50
- Issue
- 8
- Pages
- 2640-2649
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2124243126
- Cited by
- 374
- References
- 51
- FWCI
- 8.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.